FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

MICROLET®NEXT 2 Lancing Device

K Number: K250813 · Decision May 14, 2025
Classifications
1
FEI Numbers
84
Registration Numbers
84
Same Product Code
23
Applicant Total
7
Review Days
58

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MICROLET®NEXT 2 Lancing Device
K Number
K250813
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
878.4850
Medical Specialty
General, Plastic Surgery
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Ascensia Diabetes Care U.S., Inc.
Date Received
March 17, 2025
Decision Date
May 14, 2025
Product Code
QRL
Advisory Committee
General, Plastic Surgery
Review Advisory Committee
SU
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QRL Multiple Use Blood Lancet For Single Patient Use Only

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QRL), ordered by most recent decision date.

View all

Other Clearances by Ascensia Diabetes Care U.S., Inc.

K Number Device Name
K241787 CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System
K241810 MICROLET®NEXT Lancet
K223293 CONTOUR® NEXT GEN Blood Glucose Monitoring System
K220633 MICROLET NEXT lancing device, MICROLET Lancet
K162336 Contour Next EZ Blood Glucose Monitoring System
K160430 Contour Next Link Wireless Blood Glucose Monitoring System, Contour Next Blood Glucose Monitoring System